# The SIM-SOF Trial for Hepatitis C

> **NCT02168361** · PHASE4 · COMPLETED · sponsor: **Center For Hepatitis C, Atlanta, GA** · enrollment: 93 (actual)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** Pegylated Interferon alfa-2b
- **DRUG:** Simeprevir
- **DRUG:** Ribavirin
- **DRUG:** Sofosbuvir

## Key facts

- **NCT ID:** NCT02168361
- **Lead sponsor:** Center For Hepatitis C, Atlanta, GA
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-12
- **Final completion:** 2015-04
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2016-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02168361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02168361, "The SIM-SOF Trial for Hepatitis C". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02168361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*